Company announcement no.18/2010
October 1, 2010
Chr. Hansen Holding A/S plans to release its financial results and to hold its
annual general meeting in 2010/2011 on the following dates:
2010
30 November Annual General Meeting
Please note that subjects and proposals that shareholders wish to be addressed
at the Annual General Meeting will be added to the agenda if such a request is
submitted to the Board of Directors no later than on Monday 18 October at 16.00
CET.
2011
12 January Interim Report (Q1 2010/11)
6 April Interim Report (Q2 2010/11)
6 July Interim Report (Q3 2010/11)
3 November Annual Report 2010/11
29 November Annual General Meeting
Please note that subjects and proposals that shareholders wish to be addressed
at the Annual General Meeting will be added to the agenda if such a request is
submitted to the Board of Directors no later than on Monday 17 October at 16.00
CET.
For further information, please contact:
Henning Jakobsen, CFO
Tel: +45 4574 7621
Anders Mohr Christensen, Investor Relations
Tel: +45 4574 7618
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient
solutions for the food, nutritional, pharmaceutical and agricultural industries.
All solutions are based on strong research and development competencies and
significant technology investments. Revenue in FY 2008/09 was EUR 511 million.
The company enjoys market leadership in all its divisions: Cultures & Enzymes,
Health & Nutrition and Colors & Blends. There are more than 2,200 dedicated
employees in over 30 countries. For further information, please visit
www.chr-hansen.com.
